Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-16

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)

NCT06984705

Mpox (Monkeypox)

ENROLLING_BY_INVITATION

Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts

NCT07267390

Mpox (Monkeypox)

RECRUITING

Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)

NCT07067723

Monkeypox (Mpox)

ENROLLING_BY_INVITATION

Clinical and Biological Aspects of the MONKEYPOX Disease

NCT05627713

Monkey Pox

RECRUITING NA

Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox

NCT05476744

Monkeypox

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Monkeypox MPOX

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Human cases of monkeypox confirmed by PCR

Laboratory-confirmed mpox infection is defined as determined by polymerase chain reaction assay (PCR), culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 5 days of inclusion.

Viral genomic

Intervention Type DIAGNOSTIC_TEST

Evaluation of mpox viral genomic

Untargeted Metabolomics

Intervention Type DIAGNOSTIC_TEST

Evaluation of metabolomics of the total plasma, oropharynx, and skin samples.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Viral genomic

Evaluation of mpox viral genomic

Intervention Type DIAGNOSTIC_TEST

Untargeted Metabolomics

Evaluation of metabolomics of the total plasma, oropharynx, and skin samples.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged ≥ 18 years with confirmed MPOX infection.

(laboratory-confirmed monkeypox infection is defined as determined by PCR, culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 4 days of randomization)